Literature DB >> 21362650

Epigenetics and prenatal influences on asthma and allergic airways disease.

David Martino1, Susan Prescott2.   

Abstract

Uterine life is arguably the most critical time in developmental programming, when environmental exposures may have the greatest potential to influence evolving fetal structure and function. There has been substantial progress in understanding the epigenetic mechanisms through which environmental exposures can permanently alter the expression of fetal genes and contribute to the increasing propensity for many complex diseases. These concepts of "developmental origins" of disease are being applied across virtually all fields of medicine, and emerging epigenetic paradigms are the likely mechanism behind the environment-driven epidemic of asthma and allergic disease. Here, we examine the epigenetic regulation of immune development and the early immune profiles that contribute to allergic risk. In particular we review new evidence that key environmental exposures, such as microbial exposure, dietary changes, tobacco smoke, and pollutants, can induce epigenetic changes in gene expression and alter disease risk. Although most of these factors have already been clearly implicated in epidemiologic studies of asthma and allergic disease, new studies investigating the mechanisms of these effects may provide new avenues for using these pathways for disease prevention.

Entities:  

Mesh:

Year:  2011        PMID: 21362650     DOI: 10.1378/chest.10-1800

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  67 in total

Review 1.  Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an "immunodiverse" developmental state.

Authors:  Becky Adkins
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

2.  Prenatal exposures and DNA methylation in newborns: a pilot study in Durban, South Africa.

Authors:  Jaclyn M Goodrich; Poovendhree Reddy; Rajen N Naidoo; Kareshma Asharam; Stuart Batterman; Dana C Dolinoy
Journal:  Environ Sci Process Impacts       Date:  2016-07-13       Impact factor: 4.238

3.  Effect of maternal ω3 fatty acid supplementation on infant allergy.

Authors:  Christina E Ciaccio; Manika Girdhar
Journal:  Ann Allergy Asthma Immunol       Date:  2014-03       Impact factor: 6.347

4.  Associations between prenatal maternal urinary concentrations of personal care product chemical biomarkers and childhood respiratory and allergic outcomes in the CHAMACOS study.

Authors:  Kimberly Berger; Brenda Eskenazi; John Balmes; Nina Holland; Antonia M Calafat; Kim G Harley
Journal:  Environ Int       Date:  2018-10-04       Impact factor: 9.621

Review 5.  Early developmental conditioning of later health and disease: physiology or pathophysiology?

Authors:  M A Hanson; P D Gluckman
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

Review 6.  Developmental origins of inflammatory and immune diseases.

Authors:  Ting Chen; Han-Xiao Liu; Hui-Yi Yan; Dong-Mei Wu; Jie Ping
Journal:  Mol Hum Reprod       Date:  2016-05-25       Impact factor: 4.025

7.  Single parent households and increased child asthma morbidity.

Authors:  Terri Moncrief; Andrew F Beck; Jeffrey M Simmons; Bin Huang; Robert S Kahn
Journal:  J Asthma       Date:  2014-01-09       Impact factor: 2.515

Review 8.  Integrating omics technologies to study pulmonary physiology and pathology at the systems level.

Authors:  Ravi Ramesh Pathak; Vrushank Davé
Journal:  Cell Physiol Biochem       Date:  2014-04-28

9.  Associations of prenatal environmental phenol and phthalate biomarkers with respiratory and allergic diseases among children aged 6 and 7 years.

Authors:  Jessie P Buckley; Lesliam Quirós-Alcalá; Susan L Teitelbaum; Antonia M Calafat; Mary S Wolff; Stephanie M Engel
Journal:  Environ Int       Date:  2018-03-20       Impact factor: 9.621

10.  Maternal adiposity in pregnancy and offspring asthma in adulthood.

Authors:  Anna P Westberg; Minna K Salonen; Mikaela von Bonsdorff; Clive Osmond; Eero Kajantie; Johan G Eriksson
Journal:  Eur Respir J       Date:  2018-08-30       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.